U.S. Tobacco Stock News

Helios Technologies (HLIO) is back in focus after reporting fourth quarter 2025 non-GAAP earnings of $0.81 per share, which topped estimates and reflected year over year growth tied to its Electronics and Hydraulics segments. See our latest analysis for Helios Technologies. The earnings beat comes after a strong 90 day share price return of 22.96% and a very large 1 year total shareholder return. This suggests that recent momentum has been building from a low base. If this earnings move has...

In recent days, ConocoPhillips has been in focus as Middle East tensions pushed oil prices higher, while its CEO Michael Ryan Lance disclosed a US$15.03 million sale of 113,221 shares and the company continued advancing projects such as the Willow development and LNG expansions. These events underline how ConocoPhillips’ cash returns policy, reliance on large oil and gas projects, and sensitivity to geopolitical-driven commodity swings are central to how investors assess the business. We’ll...

Why Braiin Stock Is on Investor Radar Braiin (NasdaqGM:BRAI) has drawn attention after a strong 1 day move of 22.17%. This has prompted investors to reassess a business that combines agriculture services with IoT, wireless connectivity, robotics, software, and AI/ML. See our latest analysis for Braiin. The 22.17% 1 day share price return, taking Braiin to $25.18, sits against a weaker backdrop, with a 7 day share price return of 12.71% and a year to date share price return of a 43.45%...

Kratos Defense & Security Solutions (KTOS) is back in focus after an analyst upgrade highlighting its hypersonic business, along with new US Navy rocket motor work and a long-term ambition for multi-billion-dollar revenue. See our latest analysis for Kratos Defense & Security Solutions. Despite the recent pullback, with a 30 day share price return of a 21.31% decline and a year to date share price return of a 15.11% decline, Kratos still carries very strong momentum in the background, shown...

Regulatory allegations put MakeMyTrip in the spotlight Morpheus Research has released a report raising concerns about MakeMyTrip (MMYT). The report highlights allegations of anti-competitive practices, undisclosed regulatory investigations in India, and claims that the company is obscuring weakening financial performance. See our latest analysis for MakeMyTrip. The Morpheus Research allegations arrive after a sharp reset in sentiment, with MakeMyTrip’s share price at US$39.84 and a 1 year...

In recent days, Assured Guaranty director Francisco Borges sold 123,750 shares of the company, a transaction worth nearly US$9.93 million, marking a large reduction in his personal stake. This insider sale comes as Assured Guaranty balances strong profitability and a solid balance sheet with pressures from lower-yield AA business and its Assured Life Re annuity reinsurance expansion. We’ll now examine how Borges’ sizable insider sale could influence Assured Guaranty’s investment narrative,...

Nektar Therapeutics recently presented Phase 2b data for its T‑reg–enhancing biologic rezpegaldesleukin in atopic dermatitis and alopecia areata at the 2026 American Academy of Dermatology meeting, while also advancing plans for a Phase 3 atopic dermatitis program and highlighting prior Fast Track designations from the FDA. At the same time, multiple law firms have launched or promoted securities class actions alleging protocol violations and misleading disclosures in the REZOLVE-AA alopecia...

Why NorthWestern Energy Group is on investors’ radar today NorthWestern Energy Group (NWE) has recently drawn fresh attention after a period where the share price showed mixed short term moves, including a positive past 3 months return alongside a weaker month performance. See our latest analysis for NorthWestern Energy Group. The recent 1-day share price return of 1.76% and 7-day gain of 3.63% sit alongside a weaker 30-day share price return of 3.91%. Meanwhile, the 1-year total shareholder...

HarrisQuest’s European expansion as a potential catalyst Stagwell (STGW) is drawing attention after expanding The Harris Poll’s HarrisQuest platform into Europe, giving regional brands access to always-on brand and reputation tracking used by global clients such as Lucid Motors and Storck. See our latest analysis for Stagwell. The HarrisQuest expansion comes as momentum in Stagwell’s share price has been picking up, with a 30-day share price return of 20.08% and a 90-day share price return of...

In recent days, Equity LifeStyle Properties attracted fresh analyst attention as Mizuho initiated coverage with an outperform rating, while BofA Securities and BMO Capital reaffirmed their positive views on the residential REIT. Analysts emphasized the company’s comparatively strong same-store revenue and core funds from operations performance, alongside resilient manufactured home and annual RV revenue streams within the broader residential REIT sector. Next, we’ll examine how this cluster...

Recently, analysts at Sidoti cut their Q1 2026 earnings-per-share forecast for HNI Corporation to $0.31, following earlier downgrades after a Q4 2025 earnings miss in its office furniture and hearth businesses. This shift in expectations highlights growing concern that industry headwinds and execution risks may weigh more heavily on HNI’s near-term profitability than previously thought. We’ll now examine how Sidoti’s reduced Q1 2026 EPS forecast may affect HNI’s earlier investment narrative...

Elevance Health (ELV) is back in focus after strong fourth quarter earnings, a higher dividend, updated full year guidance, and a flurry of senior appointments across its Health Benefits and Carelon units. See our latest analysis for Elevance Health. The recent leadership reshuffle, strong fourth quarter results, higher dividend, and updated guidance have helped the share price rebound, with a 7 day share price return of 5.01% and a 30 day share price return of 4.98%. However, the 1 year...

Tyra Biosciences recently elevated Vice President of Finance Julia Rueb to principal accounting officer, deepened its leadership bench, advanced its dabogratinib 3x3 clinical program, and completed a US$126 million block share sale to a large investment manager. Taken together, these steps highlight Tyra’s emphasis on financial discipline and late-stage clinical execution while attracting significant institutional and analyst attention to its pipeline. We’ll now examine how the intensified...

Kymera Therapeutics (KYMR) drew fresh attention after sharing positive Phase 1b data for KT-621 in moderate to severe atopic dermatitis. The results were highlighted in a late breaking oral session at the American Academy of Dermatology meeting. See our latest analysis for Kymera Therapeutics. The fresh KT-621 Phase 1b data came on the back of strong share price momentum, with a 7 day share price return of 9.26% and a 90 day share price return of 17.37%. Over the longer term, the 1 year total...

In late March 2026, Toast, Inc. participated in the RSA Conference in San Francisco, where Director of Information Security Programs David Kosorok delivered presentations highlighting the company’s security capabilities. Ahead of these appearances, Toast drew strong investor attention as it reported 22% revenue growth with a revenue beat and was expected to deliver 40% year-over-year earnings growth for the current quarter, even though it slightly missed on EPS. We’ll now examine how this...

Noble Financial analyst M. Reichman recently cut his Q2 2026 earnings-per-unit estimate for Alliance Resource Partners from $0.65 to $0.51, signaling a softer near-term profit outlook for the coal producer. This revision highlights how quickly analyst sentiment can adjust to evolving expectations for Alliance’s coal and royalty businesses, even amid previously supportive industry conditions. We’ll explore how this reduced Q2 2026 earnings estimate may affect Alliance Resource Partners’...

GXO Logistics (GXO) is back in focus after opening new technology-focused distribution hubs in Mississauga, Ontario with Pandora and in Sant’Antonino, Switzerland, and securing NHS England’s home test kit logistics mandate. See our latest analysis for GXO Logistics. Despite the recent contract wins and new tech-heavy facilities, the share price is around US$53.08, with a 7 day share price return of 6.93% but a 30 day share price return decline of 10.17%. The 1 year total shareholder return of...

AI data centers, stubborn energy costs, and heightened geopolitical risk are all pushing reliable, carbon free power to the forefront of investment thinking. Nuclear sits at the center of that discussion, with governments, utilities, and large corporates all searching for 24/7 electricity that does not depend on weather or imported fossil fuels. Our Nuclear Renaissance screener is built to help you focus on listed companies most closely aligned with this long term trend. In this article, you...

Recently, StoneCo Ltd. announced it will release its first quarter 2026 results on May 14, 2026, and entered its quiet period on April 27, 2026, while analysts updated forecasts for earnings and revenue growth. Analysts now see StoneCo as potentially undervalued relative to its peers, with rising expectations for earnings and revenue adding to interest in its Brazilian fintech model. We'll now examine how these stronger earnings expectations and perceptions of undervaluation influence...

Viking Holdings (VIK) is back in focus after reporting fourth quarter 2025 earnings that topped expectations, supported by higher Capacity Passenger Cruise Days, stronger occupancy, and revenue per passenger, alongside ongoing fleet expansion across rivers and oceans. See our latest analysis for Viking Holdings. The better than expected quarter appears to sit behind Viking Holdings' recent momentum, with a 9.1% 7 day share price return and a very large 1 year total shareholder return, even...

Centrus Energy Corp. recently announced a past partnership with Palantir to support its expansion of uranium enrichment capacity across its operations. This collaboration highlights how advanced data and software tools could become increasingly important in optimizing complex nuclear fuel supply chains and enrichment projects. We’ll now explore how Palantir’s data platform support for enrichment expansion may influence Centrus Energy’s existing investment narrative and risk profile. Uncover...

In March 2026, Ateios Systems and Kodak announced the expansion of the Ateios RaiCore battery electrode platform to three leading cathode chemistries, LCO, LFP, and NMC, while securing third-party verification that the process eliminates PFA “forever chemicals” and aligning with NSF-backed efforts to strengthen the domestic battery supply chain. This collaboration highlights Kodak’s role as a manufacturing partner in next-generation, lower-toxicity energy storage materials, adding another...

Why Pursuit’s latest earnings update matters for investors Pursuit Attractions and Hospitality (PRSU) recently reported Q4 revenue slightly below consensus, while management emphasized record full year performance in 2025, ongoing portfolio transformation, and ambitious long term revenue and EBITDA targets. See our latest analysis for Pursuit Attractions and Hospitality. The share price has reacted positively around these updates, with a 6.82% 7 day share price return and a 12.99% 90 day...

Stellar Bancorp (STEL) recently redeemed the remaining $30.0 million of its 4.70% fixed to floating rate subordinated notes due 2029, simplifying its capital structure and removing this interest bearing obligation earlier than scheduled. See our latest analysis for Stellar Bancorp. The share price is at $36.62, and while the 1 day share price return is slightly negative, the 90 day share price return of 19.05% and 1 year total shareholder return of 49.82% point to momentum that has been...